<- Go Home
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.
Market Cap
$43.4B
Volume
4.6M
Cash and Equivalents
$3.7B
EBITDA
$2.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.8B
Profit Margin
76.60%
52 Week High
$96.12
52 Week Low
$58.93
Dividend
N/A
Price / Book Value
4.54
Price / Earnings
28.36
Price / Tangible Book Value
6.21
Enterprise Value
$39.7B
Enterprise Value / EBITDA
19.05
Operating Income
$1.9B
Return on Equity
19.14%
Return on Assets
10.65
Cash and Short Term Investments
$4.4B
Debt
$706.7M
Equity
$9.6B
Revenue
$6.3B
Unlevered FCF
$1.8B
Sector
Health Care Equipment and Supplies
Category
N/A
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick Premium